These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7922824)

  • 1. HSFC/CCS pharmaceutical roundtable: a model of contribution of industry to cardiovascular research. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society.
    Dagenais GR
    Can J Cardiol; 1994 Sep; 10(7):699-701. PubMed ID: 7922824
    [No Abstract]   [Full Text] [Related]  

  • 2. HSFC/CCS statement on the use of sildenafil. Heart and Stroke Foundation of Canada/Canadian Cardiovascular Society.
    Smith ER
    Can J Cardiol; 1999 Apr; 15(4):475. PubMed ID: 10322258
    [No Abstract]   [Full Text] [Related]  

  • 3. Canadian Task Force for Cardiovascular Science. A Joint Initiative of the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Society.
    Can J Cardiol; 1993 Oct; 9(8):699-735. PubMed ID: 8269356
    [No Abstract]   [Full Text] [Related]  

  • 4. The Heart and Stroke Foundation of Canada: committed to the recruitment, training and retention of cardiovascular researchers.
    Taylor M; Gee J
    Can J Cardiol; 2000 Aug; 16(8):965-6, 970-1. PubMed ID: 10978931
    [No Abstract]   [Full Text] [Related]  

  • 5. "Uniting scientific endeavour with public education and fund raising". International Society and Federation of Cardiology.
    de Figueiredo MB
    Hygie; 1992; 11(1):36. PubMed ID: 1548026
    [No Abstract]   [Full Text] [Related]  

  • 6. [Financial management of clinical cardiovascular research in France from 1985 to 1990].
    André-Fouët X
    Arch Mal Coeur Vaiss; 1992 Sep; 85(9):1329-34. PubMed ID: 1290395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the Heart and Stroke Foundation of Canada. Canadian excellence in research.
    Taylor M
    Can J Cardiol; 2000 Jan; 16(1):28-9. PubMed ID: 10653929
    [No Abstract]   [Full Text] [Related]  

  • 8. Canadian Society for Clinical Investigation representation to the Eastman Commission: research and development in the pharmaceutical industry--a Sisyphyian tale.
    MacLeod SM
    Clin Invest Med; 1986; 9(2):133-6. PubMed ID: 3731578
    [No Abstract]   [Full Text] [Related]  

  • 9. Academic medicine and the pharmaceutical industry: a cautionary tale.
    Guyatt G
    CMAJ; 1994 Mar; 150(6):951-3. PubMed ID: 8131127
    [No Abstract]   [Full Text] [Related]  

  • 10. Canadian drug companies fund universities.
    Spurgeon D
    Nature; 1993 Jun; 363(6429):484. PubMed ID: 8505969
    [No Abstract]   [Full Text] [Related]  

  • 11. Innovative strategic Canadian research training from TomorrOw's Research Cardiovascular Health Care Professionals (TORCH).
    Armstrong PW; Ezekowitz C; Michelakis E; Anderson T; Archer S; Ghali W; Hayward R; Jensen L; Lopaschuk G; Sheldon R
    Clin Invest Med; 2004 Feb; 27(1):33-41. PubMed ID: 15061584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disproportion of economic impact, research achievements and research support in digestive diseases in Canada.
    Beck IT
    Clin Invest Med; 2001 Feb; 24(1):12-36. PubMed ID: 11266029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funding medical and health-related research in the public interest.
    Baird PA
    CMAJ; 1996 Aug; 155(3):299-301. PubMed ID: 8705910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society.
    Can J Cardiol; 1997 Jan; 13(1):33-45. PubMed ID: 9039063
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical issues for cardiovascular physicians. Ethics Committee, Canadian Cardiovascular Society.
    Collins-Nakai R; Crelinsten G; Earle C; McLaughlin P
    Can J Cardiol; 1993 Jun; 9(5):391-7. PubMed ID: 8348390
    [No Abstract]   [Full Text] [Related]  

  • 16. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of the cardiovascular specialist physician workforce in Canada, 2004.
    Higginson LA
    Can J Cardiol; 2005 Nov; 21(13):1157-62. PubMed ID: 16308589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Ashley MJ; Carruthers SG; Lacourcière Y; McKay DW
    CMAJ; 1999 May; 160(9 Suppl):S13-20. PubMed ID: 10333849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues influencing development of the Canadian Cardiovascular Information Network.
    Davies RA; Abdullah S; Cohen E; Knudtson M; Collins-Nakai R; Lacroix C; Taylor G; Tu JV; Wilson E;
    Can J Cardiol; 2004 May; 20(6):637-41. PubMed ID: 15152296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle modifications to prevent and control hypertension. 7. Recommendations on stress management. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Spence JD; Barnett PA; Linden W; Ramsden V; Taenzer P
    CMAJ; 1999 May; 160(9 Suppl):S46-50. PubMed ID: 10333853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.